Installation completed for Elekta MRI-guided linear accelerator at MD Anderson Cancer Center

System is first of its kind in the United States
HOUSTON, October 13, 2015 – The University of Texas MD Anderson Cancer Center,
Elekta and Philips teams recently completed installation of the first high field
(1.5 Tesla) MRI-guided linear accelerator in the United States. By early next
year, the system will be operating in a non-clinical capacity.

The MRI-guided linear accelerator (MR linac) is designed to capture highly
detailed MR images of tumors and surrounding normal tissues as a patient
receives radiotherapy. These images could then be used to adapt treatment
delivery, increasing the accuracy of therapy and potentially improving treatment
outcome. Development of the world’s first high field MR linac is the mission of
the Elekta Atlantic Research Consortium headed by Elekta (NSE:EKTAb), which is
working in collaboration with MRI technology partner, Royal Philips (NYSE: PHG;
AEX: PHIA).

Earlier this year, MD Anderson Cancer Center renovated an existing radiotherapy
vault. On August 1, Elekta began delivering and installing the system
components.

“Elekta, MD Anderson and Philips teams have worked tremendously well together to
keep the installation project on schedule and with no major challenges,” says
Bill Yaeger, Executive Vice President, Region North America. “The final step –
ramping the MRI magnet up to its operational field strength – was recently
successfully completed and we are now ready to commission the system for non
-clinical testing.”

“The installation of the MR linac is going well and an example of the
cooperation between MD Anderson, Elekta and Philips,” adds Stephen Hahn, MD,
head of MD Anderson’s Division of Radiation Oncology. “We expect to have the
first non-clinical beam in January 2016. The MD Anderson Division of Radiation
Oncology is excited about the opportunities that the MR linac project is
targeted to provide to our patients. The possibility of soft tissue imaging
combined with advanced radiation delivery in a linac could allow us to provide
improved value for our patients.”

“We are proud to contribute to this ambitious project,” said Rob Cascella, CEO
Imaging Business Groups at Philips. “The installation of the MRI-guided linear
accelerator at MD Anderson is a great example of how we collaborate with other
innovators, combining technology and clinical innovation to create solutions
that will make a difference.”

Elekta and Philips completed installation of the world’s first high field MRI
-guided linear accelerator at University Medical Center Utrecht (Netherlands) at
the end of 2014.

The MRI-guided radiation therapy system is a works in progress and not available
for sale or distribution.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on October 13, 2015.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO:EKTAB. Website:
www.elekta.com.